Absence of factor V Arg306→Thr and low factor V Arg 306→Gly mutation prevalence in thai blood donors

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 2, 2004, Pages 450-452

  Chuansumrit, Ampaiwan ^a   Jarutwachirakul, Wasana ^a   Sasanakul, Werasak ^a   Rurgkhum, Saranya ^a   Kadegasem, Praguywan ^a   Kitpoka, Pimpan ^a   Sirachainan, Nongnuch ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 5; GLYCINE; THREONINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HEALTH STATUS; HUMAN; INFANT; MALE; PREVALENCE; THROMBOSIS; VOLUNTEER;

EID: 4544268468     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Angchaisuksiri P, Pingsuthiwong S, Aryuchai R, et al. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol 2000a; 65: 119-22.
2. Angchaisuksiri P, Pingsuthiwong S, Sura T, Aryuchai K, Busabaratana M, Atichartakarn V. Prevalence of the C677T methylenetetrahydrofolate reductase mutation in Thai patients with deep vein thrombosis. Acta Haematol 2000b; 103: 191-6.
3. Atichartakarn V, Pathepchotiwong K, Keorochana S, Eurvilaichit C. Deep vein thrombosis after hip surgery among Thai. Arch Intern Med 1988; 148: 1349-53.
4. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
5. Chan WP, Lee CK, Kwong YL, Lam CK, Liang R. A novel mutation of Arg 306 of factor V gene in Hong Kong Chinese. Blood 1998; 91: 1135-9.
6. Chuansumrit A, Chiemchanya S, Khowsathit P, Hotrakitya S, Chunharas A, Hathirat P. Thromboembolic complications in Thai pediatric patients. J Med Assoc Thai 2001a; 84: 681-7.
7. Chuansumrit A, Jarutwachirakul W, Sasanakul W, Rurgkhum S, Tardtong P, Hathirat P. Prevalence of factor V Leiden in Thai blood donors. J Med Assoc Thai 2001b; 84: 489-93.
8. Chumnijaraki T, Poshyachinda V. Postoperative thrombosis in Thai women. Lancet 1975; 1: 1357-8.
9. Dahlback B. Physiological anticoagulant. Resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-7.
10. Kalafatis M, Bertina RM, Rand MD, Mann KG. Characterization of molecular defect in the factor VR506Q. J Biol Chem 1995; 270: 4053-7.
11. Kalafatis M, Rand M, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 1994; 269: 31869-80.
12. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1113-4.
13. Rees DC. The population genetics of factor V Leiden (Arg 506 Gln). Br J Haematol 1996; 95: 579-86.
14. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: the European burden. Br J Haematol 1999; 105: 564-6.
15. Shen MC, Lin JS, Tsay W. Factor V Arg306→Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese. Thromb Haemost 2001; 85: 270-3.
16. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-22.
17. Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques 1991; 10: 506-13.
18. 306→Thr) associated with resistance to activated protein C. Blood 1998; 91: 1140-4.